{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:15:52Z","timestamp":1788984952803,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005942","name":"Funda\u00e7\u00e3o Butantan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bbrc.2021.01.058","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T07:45:38Z","timestamp":1612424738000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine"],"prefix":"10.1016","volume":"545","author":[{"given":"Eduardo Alfredo","family":"Adami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanni Liliane","family":"Chavez Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-3448","authenticated-orcid":false,"given":"Milena Apetito","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosue","family":"Miyaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa\u00edas","family":"Raw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dourival","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Comone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo das Neves","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Leonor","family":"Sarno de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Ant\u00f4nia","family":"Estima Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Yumi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"Meros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-8458","authenticated-orcid":false,"given":"Alessandra","family":"Soares-Schanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-241X","authenticated-orcid":false,"given":"Paulo","family":"Lee Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.01.058_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.onehlt.2015.03.001","article-title":"One health, multiple challenges: the inter-species transmission of influenza A virus","volume":"1","author":"Short","year":"2015","journal-title":"One Health"},{"key":"10.1016\/j.bbrc.2021.01.058_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081650","article-title":"Evolution of influenza A virus by mutation and Re-assortment","volume":"18","author":"Shao","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2021.01.058_bib3","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2021.01.058_bib4","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.vaccine.2013.06.071","article-title":"Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies","volume":"31","author":"Kreijtz","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib5","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/JVI.03173-15","article-title":"Two outbreak sources of influenza A (H7N9) viruses have been established in China","volume":"90","author":"Wang","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2021.01.058_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.celrep.2018.03.081","article-title":"A\u00a0gene constellation in avian influenza A (H7N9) viruses may have facilitated the fifth wave outbreak in China","volume":"23","author":"Zhu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2021.01.058_bib8","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1038\/s41598-017-10605-6","article-title":"First genome report and analysis of chicken H7N9 influenza viruses with poly-basic amino acids insertion in the hemagglutinin cleavage site","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2021.01.058_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.15585\/mmwr.mm6609e2","article-title":"Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic - China, October 2016-February 2017","volume":"66","author":"Iuliano","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.bbrc.2021.01.058_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/cit541","article-title":"Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus","volume":"57","author":"Yu","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.01.058_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jinf.2017.04.002","article-title":"Evolving HA and PB2 genes of influenza A (H7N9) viruses in the fifth wave - increasing threat to both birds and humans?","volume":"75","author":"Li","year":"2017","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.bbrc.2021.01.058_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chom.2015.02.001","article-title":"SnapShot: evolution of human influenza A viruses","volume":"17","author":"Wendel","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbrc.2021.01.058_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.micinf.2017.08.012","article-title":"Single immunization with MF59-adjuvanted inactivated whole-virion H7N9 influenza vaccine provides early protection against H7N9 virus challenge in mice","volume":"19","author":"Chang","year":"2017","journal-title":"Microb. Infect."},{"key":"10.1016\/j.bbrc.2021.01.058_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(15)00378-3","article-title":"H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Rudenko","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.01.058_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2021.01.058_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2017.09.014","article-title":"Recombinant hemagglutinin proteins formulated in a novel PELC\/CpG adjuvant for H7N9 subunit vaccine development","volume":"146","author":"Chen","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2021.01.058_bib18","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib19","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.vaccine.2016.03.037","article-title":"Analysis of the immunogenicity and bioactivities of a split influenza A\/H7N9 vaccine mixed with MF59 adjuvant in BALB\/c mice","volume":"34","author":"Ou","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib20","doi-asserted-by":"crossref","first-page":"81012","DOI":"10.18632\/oncotarget.12746","article-title":"Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A\/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine","volume":"7","author":"Ou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2021.01.058_bib21","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1016\/j.vaccine.2014.04.060","article-title":"Potency of an inactivated influenza vaccine prepared from A\/duck\/Mongolia\/119\/2008 (H7N9) against the challenge with A\/Anhui\/1\/2013 (H7N9)","volume":"32","author":"Chu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib22","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1016\/j.vaccine.2014.06.016","article-title":"A\u00a0single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets","volume":"32","author":"Wong","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59((R)) adjuvant: a phoenix that arose from the ashes","volume":"12","author":"O\u2019Hagan","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bbrc.2021.01.058_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2021.01.058_bib25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jiw414","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults","volume":"214","author":"Madan","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2021.01.058_bib27","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.vaccine.2011.04.127","article-title":"Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer","volume":"29","author":"Miyaki","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2021.01.058_bib28","series-title":"Recommendations for the Production and Control of Influenza Vaccine (Inactivated)","year":"2005"},{"issue":"6","key":"10.1016\/j.bbrc.2021.01.058_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233632","article-title":"Preparedness against pandemic influenza: production of an oil-in-water emulsion adjuvant in Brazil","volume":"15","author":"Akamatsu","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.01.058_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jfca.2014.08.007","article-title":"The impact of pH, salt concentration and heat on digestibility and amino acid modification in egg white protein","volume":"38","author":"Lass\u00e9","year":"2015","journal-title":"J.\u00a0Food Compos. Anal."},{"key":"10.1016\/j.bbrc.2021.01.058_bib31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/21645515.2015.1032490","article-title":"Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bbrc.2021.01.058_bib32","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J.\u00a0Hyg."},{"key":"10.1016\/j.bbrc.2021.01.058_bib33","doi-asserted-by":"crossref","first-page":"234ra255","DOI":"10.1126\/scitranslmed.3008761","article-title":"A\u00a0cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbrc.2021.01.058_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099322","article-title":"Response of mice and ferrets to a monovalent influenza A (H7N9) split vaccine","volume":"9","author":"Duan","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbrc.2021.01.058_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/infdis\/jiv099","article-title":"Impact of adjuvants on the immunogenicity and efficacy of split-virion H7N9 vaccine in ferrets","volume":"212","author":"Wong","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.01.058_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000488631","article-title":"The protective effects of the A\/ZJU01\/PR8\/2013 split H7N9 avian influenza vaccine against highly pathogenic H7N9 in BALB\/c mice","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2021.01.058_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/21645515.2018.1515454","article-title":"Comparative effectiveness of H7N9 vaccines in healthy individuals","volume":"15","author":"Zheng","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bbrc.2021.01.058_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-020-0187-4","article-title":"H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets","volume":"5","author":"de Jonge","year":"2020","journal-title":"NPJ Vaccines"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2100108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2100108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:01:39Z","timestamp":1757764899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2100108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"alternative-id":["S0006291X2100108X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.058","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}